Ingrid (CBD): A Comprehensive Strain Guide

Overview and Naming

Ingrid (CBD) refers to CBD-forward selections or labeled batches of the indica cultivar known as Ingrid, tailored for consumers seeking calming effects with moderated intoxication. In public sources, Ingrid is consistently categorized as an indica and described as mostly calming, with the classic, THC-dominant versions testing higher-than-average in potency according to Leafly. The CBD designation typically indicates either a balanced 1:1 THC:CBD chemotype (Type II) or a CBD-dominant chemotype (Type III) with THC substantially reduced.

Because cannabis naming is decentralized, Ingrid (CBD) can represent either a breeder-selected phenotype or a production batch whose lab certificate shows elevated CBD. In dispensaries, it is common to see the same cultivar name presented across different chemotypes, so consumers should verify lab results for exact cannabinoid ratios. Think of Ingrid (CBD) less as a single, fixed recipe and more as a calming indica framework tuned toward CBD for smoother, less racy effects.

History and Market Context

Ingrid itself is a lesser-known but steadily rising indica, recognized for its soothing profile and evening suitability. Leafly notes that Ingrid’s effects skew calming and that its potency, in THC-forward forms, trends higher than average. This reputation helped the cultivar find a niche among people who want heavy relaxation without the loud hype of mainstream, dessert-like hybrids.

The CBD turn for Ingrid followed broader market demand for gentler, functional cannabis experiences. Around festival circuits and consumer education hubs, such as the long-running Seattle Hempfest referenced by Leafly, CBD-centric cultivars became increasingly visible by the late 2010s. As education improved, many consumers learned to request specific chemotypes by ratio, opening the door for CBD iterations of familiar names like Ingrid.

The insomnia conversation also pushed indicas and balanced 1:1 ratios into the spotlight. Leafly’s condition-based listings for insomnia underscore that many patients and consumers report favoring indica-leaning, sedating options. Ingrid (CBD) stands at the intersection of these trends, combining indica relaxation with CBD’s reputation for reducing anxiety and tempering THC’s intensity.

Genetic Lineage and Breeding Notes

The publicly documented breeder origin story of Ingrid is opaque; multiple sources list it as an indica with relaxing effects, yet specific parental lines are not consistently disclosed by original breeders. This makes it wise to treat precise lineage claims with caution unless supported by breeder-published data. What is clear is that Ingrid conforms to an indica growth pattern—shorter internodes, dense flowers, and a strong body-focused effect profile.

Ingrid (CBD) variants generally arise through two common routes. The first is phenotype selection within seed populations or clone banks, where producers select for elevated CBD expressions and stabilize through clonal propagation. The second is outcrossing an Ingrid cut with a known CBD donor (for example, a Cannatonic-like or CBD Crew-derived parent), followed by backcrossing to recapture Ingrid’s structure and aroma while maintaining a higher CBD ratio.

Because these breeding routes differ, Ingrid (CBD) can present as either a balanced 1:1 or a CBD-dominant expression, depending on the source. Growers and patients should anchor their expectations to the batch-specific certificate of analysis (COA). The COA, rather than the name alone, is the most reliable indicator of cannabinoid ratio and terpene distribution.

Botanical Appearance and Structure

Ingrid typically exhibits compact, indica-leaning architecture with broad leaflets and a stout, bushy frame. Internodes are short to medium, encouraging a dense canopy that benefits from selective defoliation for light penetration. Mature flowers are tight and resinous, with calyxes stacking into rounded colas rather than elongated spears.

Bud coloration usually ranges from forest green to deeper olive, while pistils present in orange to copper shades as they mature. Trichome coverage is heavy under favorable conditions, often forming a glassy frost that signals resin density. In CBD-forward cuts, the morphology remains similar, as cannabinoid ratio has less influence on plant shape than genotype and environment.

Growers frequently note thick, sturdy lateral branches that can carry dense clusters if supported. When trained via topping or main-lining, Ingrid responds by producing multiple uniform colas. In tight spaces, low-stress training and a modest SCROG grid help prevent shading and maximize yield per square meter.

Aroma and Bouquet

Aromatically, Ingrid leans into earthy, herbal, and sweet notes that many consumers associate with sedating indicas. Common descriptors include damp forest, fresh herb garden, and a soft, creamy sweetness on the back end. Some phenotypes introduce faint skunk or cheese-like undertones, which may become more apparent when the flower is broken up.

On the plant, early-flower aromas are subtle and green, concentrating as trichomes ripen. By late flower and during cure, the bouquet deepens, often developing richer base notes and a more pronounced herbal-spice character. Environmental control during drying is crucial to lock in these aromatics; excessive heat or rapid drying can strip monoterpenes and dull the nose.

In CBD selections, expect a similar overall aroma, with terpene balance sometimes tilting toward myrcene or linalool, reinforcing the cultivar’s calming identity. Producers who slow-cure at 60–62% relative humidity often retain a more nuanced bouquet. Consumers using dry herb vaporizers at lower temperatures, such as 175–190°C, will typically perceive the herbal-sweet layer more clearly.

Flavor and Mouthfeel

On the palate, Ingrid is generally earthy and gently sweet, with herbal and pine-like accents. The inhale tends to be smooth when properly cured, while the exhale can reveal mild spice or a creamy, floral finish. Some phenotypes present a faint cheddar or lactic tang reminiscent of classic European skunk lines.

A balanced CBD expression may taste slightly less sharp, as CBD-rich flower sometimes moderates the edge of peppery or diesel-like volatiles. Vaporization at lower temperatures accentuates sweetness and herbal clarity, while higher temperatures bring out peppery beta-caryophyllene and woodsy humulene. Water-cured or over-dried samples often lose their sweetness, emphasizing earth and pepper instead.

For consistent flavor, a slow dry of 10–14 days at 60°F and 60% RH is a reliable baseline. Final curing in glass at 62% RH, with gentle burping in the first week, helps preserve volatile monoterpenes. Avoiding temperature spikes beyond 75°F during cure reduces terpene loss and prevents the flattened taste many associate with rushed drying.

Cannabinoid Profile and Chemotype

Classic Ingrid is commonly reported as high-THC and calming, aligning with Leafly’s note that it is higher in THC than average for consumer flower. In these THC-dominant batches, total THC typically ranges from 18–24% by dry weight under skilled cultivation, with CBD usually below 1%. Such expressions produce strong body effects and pronounced sedation for many users, especially in evening contexts.

Ingrid (CBD) shifts this profile toward a balanced or CBD-dominant chemotype. In 1:1-type batches (Type II), it is typical to see 6–12% THC and 6–12% CBD, with total cannabinoids often landing in the 14–22% range. In CBD-dominant batches (Type III), CBD can range from 8–18% while THC drops below 1–5%, significantly moderating intoxication while preserving physical relaxation.

Terpenes commonly total 1.5–3.0% by weight in well-grown flower, contributing materially to perceived effects. Remember that cannabinoids and terpenes are dynamic; decarboxylation during smoking or hot vaporization changes the ratio of acidic to neutral cannabinoids. Always consult the COA for the lot you are purchasing, as chemotype can vary widely by producer and harvest.

Terpene Profile and Minor Compounds

While specific terpene data vary by grower and batch, Ingrid and its CBD-labeled selections frequently express myrcene, beta-caryophyllene, limonene, linalool, and humulene. In many indica-leaning cultivars, myrcene in the 0.4–1.0% range by weight is common, and Ingrid often follows suit. Beta-caryophyllene, typically 0.2–0.6%, contributes peppery spice and binds to CB2 receptors, which may influence inflammatory pathways in preclinical models.

Limonene at 0.1–0.4% adds citrus brightness and is associated with mood-elevating reports in consumer surveys. Linalool, often 0.05–0.3%, provides floral and lavender notes and aligns with relaxing, sleep-supportive perceptions. Humulene in the 0.05–0.3% bracket adds a woody, herbal dry note, complementing the earthy base.

Minor cannabinoids such as CBC and CBG sometimes appear at 0.2–1.0% each in robust samples. Their presence can subtly shape effects, with CBG often described as clear-headed and CBC being explored for anti-inflammatory properties. These minor constituents are not guaranteed and can vary more than the primary THC:CBD ratio.

Experiential Effects and User Reports

User reports commonly frame Ingrid as calming, heavy-bodied, and best suited for evening wind-down. The CBD-forward version preserves this relaxation while moderating the mental intensity associated with higher-THC batches. Many consumers describe muscle loosening, reduced restlessness, and a smooth onset that avoids sudden peaks.

In balanced 1:1 batches, the euphoric headspace is present but controlled, and the CBD content often reduces the likelihood of racing thoughts. In CBD-dominant cuts, users often note a clearer mind with strong bodily ease and a diminished sense of time pressure, making it suitable for after-work decompression. Dry mouth and dry eyes are the most common minor adverse effects; dizziness can occur at higher doses, especially in THC-including batches.

Leafly’s general observation that Ingrid is mostly calming aligns with reports of improved readiness for sleep. Notably, Leafly’s insomnia listings highlight a trend toward indica-dominant, sedating strains among consumers seeking better sleep. Ingrid (CBD) dovetails with this pattern by combining the somatic heaviness of an indica with CBD’s tendency to take the edge off.

Potential Medical Applications (Not Medical Advice)

Ingrid (CBD) is often selected by patients seeking help with stress, anxiety, and sleep onset difficulties, consistent with the indica and CBD reputations for calming the nervous system. Balanced 1:1 THC:CBD profiles have supporting clinical evidence in other contexts: nabiximols, a pharmaceutical 1:1 oromucosal spray, has shown 20–30% improvements in patient-reported spasticity in multiple sclerosis cohorts across several trials. While smoked or vaporized flower is not the same as standardized oromucosal spray, it suggests that balanced ratios can provide both analgesic and antispasmodic benefits for some users.

CBD-dominant Ingrid batches may be chosen for daytime pain modulation where mental clarity is a priority. Preclinical and early clinical data suggest CBD has anxiolytic properties and can reduce autonomic arousal in stress tasks, which aligns with many anecdotal reports of steadier mood. For sleep, indica-leaning, myrcene- and linalool-rich profiles are commonly reported to shorten sleep latency in user surveys, though formal sleep architecture studies are mixed and highly dose-dependent.

Patients with neuropathic pain sometimes prefer 1:1 ratios for the entourage of THC-mediated analgesia and CBD-mediated modulation. Gastrointestinal discomfort and inflammatory complaints are additional reasons some patients cite for choosing CBD-forward indicas, given beta-caryophyllene’s CB2 activity in preclinical models. Always consult a clinician, particularly if you take other medications, as cannabinoids can affect cytochrome P450 metabolism and dosing is highly individual.

Cultivation Guide: Indoors, Greenhouse, and Outdoors

Ingrid behaves as a classic indica in the garden: compact, sturdy, and responsive to topping. Indoors, give 3–5 weeks of vegetative growth to fill the canopy, then plan for a flowering period of approximately 7–9 weeks depending on phenotype and desired effects. CBD-forward selections often ripen on a similar timetable, though some 1:1 phenotypes can finish a few days earlier.

Target yield indoors, under optimized conditions and dense canopy management, is 400–550 grams per square meter with 600–1000 µmol·m⁻²·s⁻¹ of PPFD in flower. Outdoors, a well-trained plant in full sun with ample root volume can produce 450–800 grams per plant, assuming a long enough season and good pest management. These figures are generalized; genetics, environment, and grower skill can swing yields by ±25%.

Greenhouse growers can capitalize on shoulder seasons with light deprivation to lock in an 8-week flower while avoiding fall rains that can promote botrytis in dense colas. Good airflow is vital; use horizontal airflow fans and prune inner larf early to reduce humidity pockets. Sturdy stakes or a net will prevent branch droop as the dense flowers pack on weight in late bloom.

Environmental Parameters and Feeding

Indoors, maintain day temperatures of 75–80°F (24–27°C) in veg and 72–78°F (22–26°C) in flower, with a night drop of 5–8°F (3–4°C). Relative humidity should be 60–70% in veg, 50–55% early to mid flower, and 40–45% in late flower. A VPD of 0.9–1.2 kPa in veg and 1.2–1.5 kPa in flower is a reliable starting target.

For lighting, provide 400–600 µmol·m⁻²·s⁻¹ PPFD in veg and 700–1000 µmol·m⁻²·s⁻¹ in flower, yielding a Daily Light Integral roughly 20–25 mol·m⁻²·day⁻¹ in veg and 35–45 mol·m⁻²·day⁻¹ in flower. CO2 supplementation to 900–1200 ppm in a sealed room can improve growth rates and bud density if light and nutrition are sufficient. In non-sealed rooms, prioritize fresh air exchange and odor control.

Nutrition-wise, aim for electrical conductivity (EC) around 1.2–1.6 in veg and 1.6–2.0 in flower, with soil or coco pH between 6.0–6.5 and hydroponic solution pH between 5.8–6.2. Ingrid tolerates moderate feeding but can tip into excess nitrogen in late veg, which tightens internodes and can delay flowering transition. Cal-mag support at 100–150 ppm Ca and 40–60 ppm Mg is prudent under high-intensity LED lighting to prevent interveinal chlorosis and tip burn.

Irrigate to 10–20% runoff in container systems to avoid salt accumulation and maintain root oxygenation. In living soil beds, rely on balanced mineralization and top-dressing with slow-release amendments, observing leaf color and vigor rather than chasing EC. Keep root zone temperatures near 68–72°F (20–22°C) to maximize nutrient uptake and microbial activity.

Training, Canopy Management, and IPM

Ingrid’s dense structure benefits from early topping at the 4th or 5th node and gentle low-stress training to open the center. A single topping followed by a SCROG net can produce 6–10 substantial colas per plant in a 3–5 gallon container. Defoliate lightly around week 3 and week 6 of flower to improve airflow without shocking the plant.

Monitor leaf surface temperature with an IR thermometer; under modern LEDs, leaves often run 2–4°F cooler than ambient, allowing slightly higher room temps without stress. Keep canopy height uniform for even PPFD distribution, reducing larf and improving cannabinoid uniformity across tops. If possible, rotate plants weekly to minimize microclimate differences.

For integrated pest management, adopt a weekly scouting schedule with sticky cards and leaf inspections. Ingrid’s thick colas can invite botrytis if RH spikes late; maintain airflow, remove interior popcorn early, and consider a preventive Bacillus subtilis or Bacillus amyloliquefaciens spray in veg only. For mites and thrips, predatory mites such as Neoseiulus californicus and Amblyseius